Squamous cell carcinoma antigen is a new member of the serine protease inhibitors
- 1 November 1991
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 181 (1) , 51-58
- https://doi.org/10.1016/s0006-291x(05)81380-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Immunocytological Distribution of the Tumor AntigenAsia-Oceania Journal of Obstetrics and Gynaecology, 2010
- Crystal structure of ovalbumin as a model for the reactive centre of serpinsNature, 1990
- Plasminogen activators and their inhibitors in the neuromuscular system: II. Serpins and serpin: Protease complex receptors increase during in vitro myogenesisJournal of Cellular Physiology, 1990
- Individualization of the Cutoff Value for Serum Squamous-Cell Carcinoma Antigen Using a Sensitive Enzyme ImmunoassayTumor Biology, 1990
- Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial Determinations and Tissue LocalizationCancer, 1985
- ‘ATG vectors’ for regulated high-level expression of cloned genes in Escherichia coliGene, 1985
- Complete nucleotide sequence of the chicken chromosomal ovalbumin gene and its biological significanceBiochemistry, 1981
- The site in human antithrombin for functional proteolytic cleavage by human thrombinFEBS Letters, 1981
- Tumor‐Antigen (TA‐4) of Squamous Cell Carcinomaits Tissue Distribution and its Relationship to Serum TA‐4 ConcentrationsAsia-Oceania Journal of Obstetrics and Gynaecology, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970